Does the time between CT scan and chemotherapy increase the risk of acute adverse reactions to iodinated contrast media in cancer patients?

被引:0
|
作者
Alberto Farolfi
Elisa Carretta
Corradina Della Luna
Angela Ragazzini
Nicola Gentili
Carla Casadei
Domenico Barone
Martina Minguzzi
Dino Amadori
Oriana Nanni
Giampaolo Gavelli
机构
[1] Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS,Department of Medical Oncology
[2] IRST IRCCS,Unit of Biostatistics and Clinical Trials
[3] IRST IRCCS,Oncology Pharmacy
[4] IRST IRCCS,IT Unit
[5] IRST IRCCS,Anesthesiology Unit
[6] IRST IRCCS,Radiology Unit
来源
BMC Cancer | / 14卷
关键词
Iodinated contrast media; Time to adverse reaction; Hypersensitivity; Contrast-enhanced CT; Cancer patients and chemotherapy;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [21] Adverse drug reactions in patients with gastroenterological diseases:: does age increase the risk?
    Dormann, H
    Krebs, S
    Muth-Selbach, U
    Criegee-Rieck, M
    Radespiel-Tröger, M
    Levy, M
    Hahn, EG
    Brune, K
    Schneider, HT
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2001, 15 (02) : 171 - 180
  • [23] Acute adverse reactions to radiographic iodinated and gadolinium-based contrast media: incidence, risk factors and premedication: From published evidence to a practical approach
    Tonolini, M.
    Bianco, R.
    CLINICA TERAPEUTICA, 2011, 162 (06): : 591 - 594
  • [24] Hypersensitivity reactions to iodinated contrast media in Italy: a retrospective study. Characteristics of patients and risk factors
    Voltolini, S.
    Cofini, V
    Murzilli, F.
    Bignardi, D.
    Borro, M.
    Calamari, M.
    Caruso, C.
    Cittadini, G.
    Contatore, M.
    Cortellini, G.
    Desideri, G.
    Di Paolo, C.
    Lippolis, D.
    Lobene, M.
    Manzotti, G.
    Meucci, E.
    Necozione, S.
    Ramirez, G. A.
    Rollandi, G. A.
    Yacoub, M. R.
    Bilo, M. B.
    EUROPEAN ANNALS OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 54 (02) : 60 - 67
  • [25] Are there any differences in acute adverse reactions among five low-osmolar non-ionic iodinated contrast media?
    Gomi, Tatsuya
    Nagamoto, Masashi
    Hasegawa, Makoto
    Katoh, Asako
    Sugiyama, Miki
    Murata, Nozomu
    Kunihiro, Toshiyuki
    Kohda, Ehiichi
    EUROPEAN RADIOLOGY, 2010, 20 (07) : 1631 - 1635
  • [26] Are there any differences in acute adverse reactions among five low-osmolar non-ionic iodinated contrast media?
    Tatsuya Gomi
    Masashi Nagamoto
    Makoto Hasegawa
    Asako Katoh
    Miki Sugiyama
    Nozomu Murata
    Toshiyuki Kunihiro
    Ehiichi Kohda
    European Radiology, 2010, 20 : 1631 - 1635
  • [27] Changes in Risk of Immediate Adverse Reactions to Iodinated Contrast Media by Repeated Administrations in Patients with Hepatocellular Carcinoma (vol 8, e76018, 2013)
    Fujiwara, N.
    Tateishi, R.
    Akahane, M.
    Taguri, M.
    Minami, T.
    PLOS ONE, 2014, 9 (03):
  • [28] Clinical observation of adverse drug reactions to non-ionic iodinated contrast media in population with underlying diseases and risk factors
    Li, Xue
    Liu, Heng
    Zhao, Li
    Liu, Junling
    Cai, Li
    Liu, Lei
    Zhang, Weiguo
    BRITISH JOURNAL OF RADIOLOGY, 2017, 90 (1070):
  • [29] Intradermal testing is helpful in confirming delayed cutaneous adverse reactions to iodinated radio contrast media and in identifying low risk alternatives
    Kennard, Lucinda
    Sellaturay, Priya
    Nasser, Shuaib
    Wagner, Annette
    CLINICAL AND EXPERIMENTAL ALLERGY, 2017, 47 (12): : 1693 - 1694
  • [30] Response to letter by Doss: addition of diagnostic CT scan does not increase the cancer risk in patients undergoing SPECT studies
    Gunnar Brix
    Elke A. Nekolla
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 148 - 149